Sawai Group Holdings Co Ltd (4887) Stock Price & News

Q2 2027 earnings • in 3 days

See details

4887:TYO

Sawai Group Holdings Co Ltd

¥1,629.00

-1.93%

(-32.00) 1D

Nov 13, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4887...

Open

¥1,675

High

¥1,690

Low

¥1,607

Mkt. cap

188.45B

Avg. vol.

517.14K

Volume

612.80K

Dividend

3.38%

Quarterly dividend

¥14

Ex-dividend date

Sep 29, 2026

P/E ratio

23.61

52-wk high

¥2,447

52-wk low

¥1,550

EPS

¥69

No. of employees

Open

¥1,675

High

¥1,690

Low

¥1,607

Mkt. cap

188.45B

Avg. vol.

517.14K

Volume

612.80K

Dividend

3.38%

Quarterly dividend

¥14

Ex-dividend date

Sep 29, 2026

P/E ratio

23.61

52-wk high

¥2,447

52-wk low

¥1,550

EPS

¥69

No. of employees

Related stocks

4553

Towa Pharmaceutical Co Ltd

¥3,345.00

-1.04%

4577

Daito Pharmaceutical Co Ltd

¥1,317.00

-0.30%

4568

Daiichi Sankyo Co Ltd

¥2,852.50

-0.17%

4539

Nippon Chemiphar Co Ltd

¥1,515.00

-0.85%

News stories

From web sources and news partners

TradingView

5 hours ago

Sawai Group Holdings Co : Higher sales lifted revenue, but costs and inventory losses cut FY2026 profit guidance

About Sawai Group Holdings Co Ltd

CEO-

Employees3.63K

Founded1929

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitesawaigroup.holdings

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	49.33B	56.02B	46.81B	51.62B
Cost of goods sold	35.01B	38.94B	34.86B	36.55B
Cost of revenue	35.01B	38.94B	34.86B	36.55B
Research and development expenses	2.82B	3.55B	3.59B	2.97B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.94B	5.96B	8.12B	7.02B
Operating expense	12.77B	9.67B	7.98B	10.12B
Total operating expenses	47.78B	48.61B	42.84B	46.67B
Operating income	1.56B	7.41B	3.98B	4.95B
Other non operating income	-1.00M	-1.00M	-285.00M	-2.00M
EBT including unusual items	1.16B	6.84B	-529.00M	4.44B
EBT excluding unusual items	1.16B	6.84B	3.46B	4.44B
Income tax expense	7.00M	1.97B	-1.18B	1.58B
Effective tax rate	0.60%	28.74%	223.63%	35.60%
Other operating expenses	4.00B	156.00M	-3.73B	128.00M
Net income	955.00M	4.90B	-311.00M	2.43B
Net profit margin	1.94%	8.75%	-0.66%	4.71%
Earnings per share	-	-	-	-
Interest and investment income	-	20.00M	-	54.00M
Interest expense	-395.00M	-589.00M	-228.00M	-562.00M
Net interest expenses	-395.00M	-569.00M	-228.00M	-508.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	5.46B	11.40B	8.22B	9.30B
Gain or loss from assets sale	56.00M	56.00M	1.90B	128.00M

Finance

Ask anything